Trial to Evaluate Investigational Drug PRAX-944 in the

Recruiting

18 years - 99 years

All

Phase 2

112 participants needed

1 Location

Brief description of study

The main goal of this study is to learn how well the study drug works at reducing tremors and how safe and well tolerated the study drug is compared with placebo in patients with ET.

Detailed description of study

The main goal of this study is to learn how well the study drug works at reducing tremors and how safe and well tolerated the study drug is compared with placebo in patients with ET.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

Conditions: Essential Tremor, ET
Age: 18 years - 99 years
Gender: All

Adults with Essential Tremor

Updated on 04 Aug 2024. Study ID: 850888

Find a site

Your Information has been sent successfully.

We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.

Would you like to be notified about other trials? Sign up for Patient Notification Services.

Send a message

Enter your contact details to connect with study team

Primary Contact

First name*

Last name*

Email*

Phone number*

Preferred way of contact

Race

Ethnicity

Are you Healthy Volunteer

Are you comfortable with the informed consent process?

Yes

Other language

By sending a message, I agree that my data will be sent to a representative for the selected site and processed in accordance with this website's Privacy Policy (see link in footer).

Trial to Evaluate Investigational Drug PRAX-944 in the Treatment of Adults with Essential Tremor

Brief description of study

Detailed description of study

Eligibility of study

Find a site

Interested in the study